Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


10.12.2018

1 Acta Haematol
1 AIDS
3 Blood
3 Bone Marrow Transplant
3 Cancer
2 Int J Hematol
1 J Pediatr Hematol Oncol
5 Leuk Lymphoma
2 Leuk Res
1 Leukemia


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Haematol

  1. WANG L, Xu J, Tian X, Lv T, et al
    Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia.
    Acta Haematol. 2018;141:43-53.
    PubMed     Text format     Abstract available


    AIDS

  2. NASREDDINE R, de Wind R, De Wit S, Martin C, et al
    HIV virological failure in a patient with human T-lymphotropic virus type 1-associated leukemia.
    AIDS. 2019;33:159-160.
    PubMed     Text format    


    Blood

  3. PASSET M, Boissel N, Sigaux F, Saillard C, et al
    PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.
    Blood. 2018 Dec 3. pii: blood-2018-10-882142. doi: 10.1182/blood-2018-10-882142.
    PubMed     Text format    

  4. QIAN M, Xu H, Perez-Andreu V, Roberts KG, et al
    Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics.
    Blood. 2018 Dec 3. pii: blood-2018-07-862946. doi: 10.1182/blood-2018-07-862946.
    PubMed     Text format     Abstract available

  5. STEIN EM, DiNardo CD, Fathi AT, Pollyea DA, et al
    Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.
    Blood. 2018 Dec 3. pii: blood-2018-08-869008. doi: 10.1182/blood-2018-08-869008.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  6. GRIMM J, Bill M, Jentzsch M, Beinicke S, et al
    Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation.
    Bone Marrow Transplant. 2018 Nov 30. pii: 10.1038/s41409-018-0413.
    PubMed     Text format     Abstract available

  7. HU Y, Wang J, Wei G, Yu J, et al
    A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2018 Dec 5. pii: 10.1038/s41409-018-0403.
    PubMed     Text format     Abstract available

  8. SUN W, Mo XD, Zhang XH, Xu LP, et al
    Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patients.
    Bone Marrow Transplant. 2018 Dec 5. pii: 10.1038/s41409-018-0406.
    PubMed     Text format     Abstract available


    Cancer

  9. BODDU PC, Kadia TM, Garcia-Manero G, Cortes J, et al
    Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31885.
    PubMed     Text format     Abstract available

  10. YOON JH, Min GJ, Park SS, Jeon YW, et al
    Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31874.
    PubMed     Text format     Abstract available

  11. KANAGAL-SHAMANNA R, Jain P, Patel KP, Routbort M, et al
    Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.
    Cancer. 2018 Dec 3. doi: 10.1002/cncr.31831.
    PubMed     Text format     Abstract available


    Int J Hematol

  12. TACHIBANA T, Koyama S, Andou T, Ishiyama Y, et al
    Salvage and bridging to allogeneic hematopoietic cell transplantation with ponatinib in patients with relapsed or refractory Philadelphia chromosome-positive leukemia.
    Int J Hematol. 2018 Dec 3. pii: 10.1007/s12185-018-02571.
    PubMed     Text format     Abstract available

  13. DOTSON J, Elhamdani A, Petryna E, Jamil MO, et al
    Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin.
    Int J Hematol. 2018 Dec 3. pii: 10.1007/s12185-018-2558.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  14. LEPE-ZUNIGA JL, Ramirez-Nova V
    Delaying Induction Therapy in Children With Newly Diagnosed Lymphoblastic Leukemia: Is that a Viable Strategy to Decrease Early Mortality?
    J Pediatr Hematol Oncol. 2018 Dec 4. doi: 10.1097/MPH.0000000000001388.
    PubMed     Text format    


    Leuk Lymphoma

  15. JIANG X, Cheng Y, Hu C, Zhang A, et al
    MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5.
    Leuk Lymphoma. 2018 Dec 5:1-12. doi: 10.1080/10428194.2018.1543875.
    PubMed     Text format     Abstract available

  16. KIM S, Freeland-Graves JH, Babaei M, Sachdev PK, et al
    Quantifying the association between acute leukemia and serum zinc, copper, and selenium: a meta-analysis.
    Leuk Lymphoma. 2018 Dec 5:1-9. doi: 10.1080/10428194.2018.1540043.
    PubMed     Text format     Abstract available

  17. MOLICA S, Giannarelli D, Mirabelli R, Levato L, et al
    The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis.
    Leuk Lymphoma. 2018 Dec 5:1-6. doi: 10.1080/10428194.2018.1543882.
    PubMed     Text format     Abstract available

  18. MICHAILOV Y, Lunenfeld E, Kapelushnik J, Huleihel M, et al
    Leukemia and male infertility: past, present, and future.
    Leuk Lymphoma. 2018 Dec 3:1-10. doi: 10.1080/10428194.2018.1533126.
    PubMed     Text format     Abstract available

  19. OCK CY, Seo H, Kim DY, Min BJ, et al
    Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia.
    Leuk Lymphoma. 2018 Dec 3:1-7. doi: 10.1080/10428194.2018.1542142.
    PubMed     Text format     Abstract available


    Leuk Res

  20. KANG KH, Kim SH, Choi SY, Yoo HL, et al
    Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.
    Leuk Res. 2018 Nov 27. pii: S0145-2126(18)30444.
    PubMed     Text format     Abstract available

  21. DE QUEIROZ MENDONCA C, Freire MV, Viana SS, Silva Tavares MKG, et al
    Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients.
    Leuk Res. 2018;76:24-28.
    PubMed     Text format     Abstract available


    Leukemia

  22. HU X, Xu S, Chen Y, Gao Z, et al
    Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis.
    Leukemia. 2018 Dec 5. pii: 10.1038/s41375-018-0301.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: